Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis

. 2005 May ; 52 (1-2) : 182-92.

Jazyk angličtina Země Česko Médium print

Typ dokumentu srovnávací studie, časopisecké články, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/pmid16004378

Grantová podpora
AI31788 NIAID NIH HHS - United States
AI52035 NIAID NIH HHS - United States
R01 AI031788 NIAID NIH HHS - United States
R21 AI069953 NIAID NIH HHS - United States
R21 AI052035 NIAID NIH HHS - United States

The Microsporidia have been reported to cause a wide range of clinical diseases particularly in patients that are immunosuppressed. They can infect virtually any organ system and cases of gastrointestinal infection, encephalitis, ocular infection, sinusitis, myositis and disseminated infection are well described in the literature. While benzimidazoles such as albendazole are active against many species of Microsporidia, these drugs do not have significant activity against Enterocytozoon bieneusi. Fumagillin, ovalicin and their analogues have been demonstrated to have antimicrosporidial activity in vitro and in animal models of microsporidiosis. Fumagillin has also been demonstrated to have efficacy in human infections due to E. bieneusi. Fumagillin is an irreversible inhibitor of methionine aminopeptidase type 2 (MetAP2). Homology cloning employing the polymerase chain reaction was used to identify the MetAP2 gene from the human pathogenic microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, Encephalitozoon intestinalis, Brachiola algerae and E. bieneusi. The full-length MetAP2 coding sequence was obtained for all of the Encephalitozoonidae. Recombinant E. cuniculi MetAP2 was produced in baculovirus and purified using chromatographic techniques. The in vitro activity and effect of the inhibitors bestatin and TNP-470 on this recombinant microsporidian MetAP2 was characterized. An in silico model of E. cuniculi MetAP2 was developed based on crystallographic data on human MetAP2. These reagents provide new tools for the development of in vitro assay systems to screen candidate compounds for use as new therapeutic agents for the treatment of microsporidiosis.

Zobrazit více v PubMed

BONTEMS F, le FLOCH P, DUFFIEUX F, BIDERRE C, PEYRET P, LALLEMAND J-Y. Homology modeling and calculation of the cobalt cluster charges of the Encephalitozoon cuniculi methionine aminopeptidase, a potential target for drug design. Biophys. Chem. 2003;105:29–43. PubMed

CALI A, KOTLER DP, ORENSTEIN JM. Septata intestinalis n. g., n. sp., an intestinal microsporidian associated with chronic diarrhea and dissemination in AIDS patients. J. Eukaryot. Microbiol. 1993;40:101–112. PubMed

CALI A, TAKVORIAN PM. Ultrastructure and development of Pleistophora ronneafiei n. sp., a microsporidium (Protista) in the skeletal muscle of an immunocompromised individual. J. Eukaryot. Microbiol. 2003;50:77–85. PubMed

CALI A, TAKVORIAN PM, LEWIN S, RENDEL M, SIAN CS, WITTNER M, TANOWITZ HB, KEOHANE E, WEISS LM. Brachiola vesicularum, n. g., n. sp., a new microsporidium associated with AIDS and myositis. J. Eukaryot. Microbiol. 1998;45:240–251. PubMed

CHANG YH, TEICHERT U, SMITH JA. Purification and characterization of a methionine aminopeptidase from Saccharomyces cerevisiae. J. Biol. Chem. 1990;265:19892–19897. PubMed

COSTA SF, WEISS LM. Drug treatment of microsporidiosis. Drug. Resist. Updat. 2000;3:384–399. PubMed

COYLE C, KENT M, TANOWITZ HB, WITTNER M, WEISS LM. TNP-470 is an effective antimicrosporidial agent. J. Infect. Dis. 1998;177:515–518. PubMed

COYLE CM, WEISS LM, RHODES LV, 3rd, CALI A, TAKVORIAN PM, BROWN DF, VISVESVARA GS, XIAO L, NAKTIN J, YOUNG E, GARECA M, COLASANTE G, WITTNER M. Fatal myositis due to the microsporidian Brachiola algerae, a mosquito pathogen. N. Engl. J. Med. 2004;351:42–47. PubMed PMC

DENGJEL B, ZAHLER M, HERMANNS W, HEINRITZI K, SPILLMANN T, THOMSCHKE A, LOSCHER T, GOTHE R, RINDER H. Zoonotic potential of Enterocytozoon bieneusi. J. Clin. Microbiol. 2001;39:4495–4499. PubMed PMC

DEPLAZES P, MATHIS A, WEBER R. Epidemiology and zoonotic aspects of microsporidia of mammals and birds. Contrib. Microbiol. 2000;6:236–260. PubMed

DESPORTES I, LE CHARPENTIER Y, GALIAN A, BERNARD FB, COCHAND-PRIOLLET B, LAVERGNE A, RAVISSE P, MODIGLIANI R. Occurrence of a new microsporidian: Enterocytozoon bieneusi n. g., n. sp., in the enterocytes of a human patient with AIDS. J. Protozool. 1985;32:250–254. PubMed

DIDIER ES. Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro. Antimicrob. Agents Chemother. 1997;41:1541–1546. PubMed PMC

DIDIER ES, DIDIER PJ, FRIEDBERG DN, STENSON SM, ORENSTEIN JM, YEE RW, TIO FO, DAVIS RM, VOSSBRINCK C, MILLICHAMP N, SHAD-DUCK JA. Isolation and characterization of a new human microsporidian, Encephalitozoon hellem (n. sp.) from three AIDS patients with keratoconjunctivitis. J. Infect. Dis. 1991;163:617–621. PubMed

DIDIER ES, MADDRY JA, KWONG CD, GREEN LC, SNOWDEN KF, SHADDUCK JA. Screening of compounds for antimicrosporidial activity in vitro. Folia Parasitol. 1998;45:129–139. PubMed

DIDIER ES, MARTIN AD, STOVALL ME, ALVAREZ X, MITTLEIDER D, GREEN LC, BOWERS LC, PLAUCHE AK, DIDIER PJ, BRINDLEY PJ. Methionine aminopeptidase 2 expression in microsporidia. J. Eukaryot. Microbiol. 2003;50:569–571. PubMed

DIDIER ES, ROGERS LB, ORENSTEIN JM, BAKER MD, VOSSBRINCK CR, VAN GOOL T, HARTSKEERL R, SOAVE R, BEAUDET LM. Characterization of Encephalitozoon (Septata) intestinalis isolates cultured from nasal mucosa and bronchoalveolar lavage fluids of two AIDS patients. J. Eukaryot. Microbiol. 1996;43:34–43. PubMed

DIETERICH DT, LEW EA, KOTLER DP, POLES MA, ORENSTEIN JM. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. J. Infect. Dis. 1994;169:178–183. PubMed

DOWD SE, GERBA CP, PEPPER IL. Confirmation of the human-pathogenic microsporidia Enterocytozoon bieneusi, Encephalitozoon intestinalis, and Vittaforma corneae in water. Appl. Environ. Microbiol. 1998;64:3332–3335. PubMed PMC

FIELD AS, MARRIOTT DJ, MILLIKEN ST, BREW BJ, CANNING EU, KENCH JG, DARVENIZA P, HARKNESS JL. Myositis associated with a newly described microsporidian, Trachipleistophora hominis, in a patient with AIDS. J. Clin. Microbiol. 1996;34:2803–2811. PubMed PMC

FRANSSEN FFJ, LUMEIJ JT, VANKNAPEN F. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrob. Agents Chemother. 1995;39:1265–1268. PubMed PMC

FREEMAN M, YOKOYAMA H, OGAWA K. A microsporidian parasite of the genus Spraguea in the nervous tissues of the Japanese anglerfish Lophius litulon. Folia Parasitol. 2004;51:167–176. PubMed

GRIFFITH EC, SU Z, TURK BE, CHEN S, CHANG YH, WU Z, BIEMANN K, LIU JO. Methionine aminopeptidase (type 2) is the common target for angio-genesis inhibitors AGM-1470 and ovalicin. Chem. Biol. 1997;4:461–471. PubMed

HAN CK, AHN SK, CHOI NS, HONG RK, MOON SK, CHUN HS, LEE SJ, KIM JW, HONG CI, KIM D, YOON JH, NO KT. Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2. Bioorg. Med. Chem. Lett. 2000;10:39–43. PubMed

HIGGINS MJ, KENT ML, MORAN JD, WEISS LM, DAWE SC. Efficacy of the fumagillin analog TNP-470 for Nucleospora salmonis and Loma salmonae infections in chinook salmon Oncorhynchus tshawytscha. Dis. Aquat. Org. 1998;34:45–49. PubMed

HOLLISTER WS, CANNING EU, WILLCOX A. Evidence for widespread occurrence of antibodies to Encephalitozoon cuniculi (Microspora) in man provided by ELISA and other serological tests. Parasitology. 1991;102:33–43. PubMed

KATINKA MD, DUPRAT S, CORNILLOT E, MÉTÉNIER G, THOMARAT F, PRENSIER G, BARBE V, PEYRETAILLADE E, BROTTIER P, WINCKER P, DELBAC F, El ALAOUI H, PEYRET P, SAURIN W, GOUY M, WEISSENBACH J, VIVARÈS CP. Genome sequence and gene compaction of the eukaryote parasite Encephalitozoon cuniculi. Nature. 2001;414:450–453. PubMed

KATIYAR SK, GORDON VR, MCLAUGHLIN GL, EDLIND TD. Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence. Anti-microb. Agents Chemother. 1994;38:2086–2090. PubMed PMC

KATSNELSON H, JAMIESON CA. Control of Nosema disease of honeybees with fumagillin. Science. 1952;115:70–72. PubMed

KEELING PJ. Congruent evidence from alpha-tubulin and beta-tubulin gene phylogenies for a zygomycete origin of microsporidia. Fungal Genet. Biol. 2003;38:298–309. PubMed

KEELING PJ, DOOLITTLE WF. Methionine aminopeptidase-1: the MAP of the mitochondrion? Trends Biochem. Sci. 1996;21:285–286. PubMed

KEOHANE EM, ORR GA, TAKVORIAN PM, CALI A, TANOWITZ HB, WITTNER M, WEISS LM. Purification and characterization of a microsporidian polar tube protein. Mol. Biochem. Parasitol. 1996;79:255–259. PubMed

KEOHANE EM, ORR GA, ZHANG HS, TAKVORIAN PM, CALI A, TANOWITZ HB, WITTNER M, WEISS LM. The molecular characterization of the major polar tube protein gene from Encephalitozoon hellem, a microsporidian parasite of humans. Mol. Biochem. Parasitol. 1998;94:227–236. PubMed PMC

LI X, CHANG YH. Amino-terminal protein processing in Saccharomyces cerevisiae is an essential function that requires two distinct methionine aminopeptidases. Proc. Natl. Acad. Sci. USA. 1995;92:12357–12361. PubMed PMC

LI X, CHANG YH. Evidence that the human homologue of a rat initiation factor-2 associated protein (p67) is a methionine aminopeptidase. Biochem. Biophys. Res. Commun. 1996;227:152–159. PubMed

LIU S, WIDOM J, KEMP CW, CREWS CM, CLARDY J. Structure of human methionine aminopeptidase-2 complexed with fumagillin. Science. 1998;282:1324–1327. PubMed

LORES B, LOPEZ-MIRAGAYA I, ARIAS C, FENOY S, TORRES J, del AGUILA C. Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human immunodeficiency virus-negative patients from Vigo, Spain. Clin. Infect. Dis. 2002;34:918–921. PubMed

LOWTHER WT, MATTHEWS BW. Structure and function of the methionine aminopeptidases. Biochim. Biophys. Acta. 2000;1477:157–167. PubMed

LUO QL, LI JY, LIU ZY, CHEN LL, LI J, QIAN Z, SHEN Q, LI Y, LUSHINGTON GH, YE QZ, NAN FJ. Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae. J. Med. Chem. 2003;46:2631–2640. PubMed

MILLERSHIP JJ, CHAPPELL C, OKHUYSEN PC, SNOWDEN KF. Characterization of aminopeptidase activity from three species of microsporidia: Encephalitozoon cuniculi, Encephalitozoon hellem, and Vittaforma corneae. J. Parasitol. 2002;88:843–848. PubMed

MOLINA JM, TOURNEUR M, SARFATI C, CHEVRET S, DE GOUVELLO A, GOBERT JG, BALKAN S, DEROUIN F, Agence Nationale de Recherches sur le SIDA 090 Study Group Fumagillin treatment of intestinal microsporidiosis. N. Engl. J. Med. 2002;346:1963–1969. PubMed

RABODONIRINA M, COTTE L, RADENNE S, BESADA E, TREPO C. Microsporidiosis and transplantation: a retrospective study of 23 cases. J. Eukaryot. Microbiol. 2003;50:583. PubMed

ROSBERGER DF, SERDAREVIC ON, ERLANDSON RA, BRYAN RT, SCHWARTZ DA, VISVESVARA GS, KEENAN PC. Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea. 1993;12:261–265. PubMed

SALI A, OVERINGTON JP. Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci. 1994;3:1582–1596. PubMed PMC

SHADDUCK JA. Effect of fumagillin on in vitro multiplication of Encephalitozoon cuniculi. J. Protozool. 1980;27:202–208. PubMed

SHEORAN AS, FENG X, KITAKA S, GREEN L, PEARSON C, DIDIER ES, CHAPMAN S, TUMWINE JK, TZIPORI S. Purification of Enterocytozoon bieneusi from stool and production of specific antibodies. J. Clin. Microbiol. 2005;43:387–392. PubMed PMC

SILVEIRA H, CANNING EU. Vittaforma corneae n. comb. for the human microsporidium Nosema corneum Shadduck, Meccoli, Davis and Font, 1990, based on its ultrastructure in the liver of experimentally infected athymic mice. J. Eukaryot. Microbiol. 1995;42:158–165. PubMed

SIN N, MENG L, WANG MQ, WEN JJ, BORNMANN WG, CREWS CM. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. USA. 1997;94:6099–6103. PubMed PMC

SLAMOVITS CH, FAST NM, LAW JS, KEELING PJ. Genome compaction and stability in microsporidian intracellular parasites. Curr. Biol. 2004;14:891–896. PubMed

SPRAGUE V, BECNEL JJ, HAZARD EI. Taxonomy of phylum Microspora. Crit. Rev. Microbiol. 1992;18:285–395. PubMed

TAKVORIAN PM, CALI A. The ultrastructure of spores (Protozoa: Microsporida) from Lophius americanus, the angler fish. J. Protozool. 1986;33:570–575. PubMed

TAKVORIAN PM, CALI A. Enzyme histochemical identification of the Golgi apparatus in the microsporidian, Glugea stephani. J. Eukaryot. Microbiol. 1994;41:63S–64S. PubMed

TAYLOR A. Aminopeptidases: structure and function. FASEB J. 1993;7:290–298. PubMed

TUMWINE JK, KEKITIINWA A, NABUKEERA N, AKIYOSHI DE, BUCKHOLT MA, TZIPORI S. Enterocytozoon bieneusi among children with diarrhea attending Mulago Hospital in Uganda. Am. J. Trop. Med. Hyg. 2002;67:299–303. PubMed

TURK BE, SU Z, LIU JO. Synthetic analogues of TNP-470 and ovalicin reveal a common molecular basis for inhibition of angiogenesis and immunosuppression. Bioorg. Med. Chem. 1998;6:1163–1169. PubMed

WANG J, SHEPPARD GS, LOU P, KAWAI M, PARK C, EGAN DA, SCHNEIDER A, BOUSKA J, LESNIEWSKI R, HENKIN J. Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese. Biochemistry. 2003;42:5035–5042. PubMed

WEBER R, BRYAN RT. Microsporidial infections in immunodeficient and immunocompetent patients. Clin. Infect. Dis. 1994;19:517–521. PubMed

WEBER R, DEPLAZES P, FLEPP M, MATHIS A, BAU-MANN R, SAUER B, SCHNEIDER A, BOUSKA J, LESNIEWSKI R, HENKIN J. Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N. Engl. J. Med. 1997;336:474–478. PubMed

WEBER R, DEPLAZES P, SCHWARTZ D. Diagnosis and clinical aspects of human microsporidiosis. Contrib. Microbiol. 2000;6:166–192. PubMed

WEISS LM. Molecular phylogeny and diagnostic approaches to microsporidia. Contrib. Microbiol. 2000;6:209–235. PubMed

WEISS LM, COSTA SF, ZHANG H. Microsporidian methionine aminopeptidase type 2. J. Eukaryot. Microbiol. 2001;48(Suppl.):88S–90S. PubMed

WEISS LM, EDLIND TD, VOSSBRINCK CR, HASHIMOTO T. Microsporidian molecular phylogeny: the fungal connection. J. Eukaryot. Microbiol. 1999;46:17S–18S. PubMed

WEISS LM, ZHOU GC, ZHANG H. Characterization of recombinant microsporidian methionine amino-peptidase type 2. J. Eukaryot. Microbiol. 2003;50:597–599. PubMed

WILLIAMS BA, HIRT RP, LUCOCQ JM, EMBLEY TM. A mitochondrial remnant in the microsporidian Trachipleistophora hominis. Nature. 2002;418:865–869. PubMed

WITTNER M, WEISS LM. The Microsporidia and Microsporidiosis. ASM Press; Washington, D.C.: 1999. p. 577.

ZHOU Y, GUO XC, YI T, YOSHIMOTO T, PEI D. Two continuous spectrophotometric assays for methionine aminopeptidase. Anal. Biochem. 2000;280:159–165. PubMed

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...